The FDA has accepted Pharming Group’s supplemental new drug application for leniolisib in treating activated phosphoinositide ...
Questions from parents largely stem from recent changes to recommendations from the Centers for Disease Control and Prevention. But, experts tell TODAY.com, that the science behind the vaccines has ...
In cases of bacterial meningitis, treatment with antibiotics must start as soon as possible, according to the CDC. "The ...
About six months ago, a series of patients came to me begging for weight-loss injections to manage obesity. As doctor who has ...
A new Advisory Committee on Immunization Practices (ACIP) workgroup will review childhood and adolescent immunization schedules, a move that infectious disease experts caution could be another step in ...
Jessica Simpson may have been delivering pop-star icon in the early 2000s, but she revealed that behind those famous abs was ...
A bronchiectasis action management plan for children significantly improved flu vaccine uptake but not the level of unscheduled doctor visits.
Afrezza is a rapid-acting inhaled human insulin that is currently approved to improve glycemic control in adults with diabetes mellitus.
The US Food and Drug Administration has approved the supplemental new drug application for Zoryve (roflumilast) cream 0.05 percent for the topical treatment of mild-to-moderate atopic dermatitis in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results